Want to see IN:SAGILITY full AI Analyst Report?
Sagility India Limited (SAGILITY) AI Stock Analysis
Sagility India Limited
(NSE:SAGILITY)
The score is driven primarily by improving fundamentals: strong revenue scale-up, materially better profitability, and a significantly de-risked balance sheet. This is tempered by inconsistencies in margin/cash conversion quality and a mixed technical picture with neutral momentum and limited near-term strength. Valuation is moderate with a low dividend yield, providing neither a strong discount nor major support.
Sagility India Limited (SAGILITY) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 212.39B
- Dividend Yield
- 0.71%
- Average Volume (3M)
- 1.84M
- Price to Earnings (P/E)
- 19.1
- Beta (1Y)
- 1.10
- Revenue Growth
- 28.49%
- EPS Growth
- 28.48%
- Country
- India
- Employees
- 47,315
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Healthcare Information Services
Sagility India Limited Business Overview & Revenue Model
Company Description
Headquartered in Bengaluru, India, and established in 2021, Sagility India Limited specializes in providing comprehensive business process management (BPM) services. The company primarily caters to clients within the healthcare and insurance industri...
How the Company Makes Money
Sagility primarily makes money by delivering outsourced, technology-enabled business services to healthcare organizations under long-term service contracts. Revenue is generated from fees charged for executing specific processes (e.g., contact-center...
Sagility India Limited Financial Statement Overview
Summary
Strong multi-year scale-up and profitability improvement, with net margin reaching 12.9% in FY2026 and EBITDA margin holding in the mid-20% range. Balance-sheet risk has fallen meaningfully as debt-to-equity improved to 0.11x by FY2026. Offsetting factors include gross-margin volatility (including an apparent outlier) and less consistent cash conversion in FY2026 (operating cash flow ~0.61x of net income).
Income Statement
74PositiveBalance Sheet
82Very PositiveCash Flow
71Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.91B | 71.93B | 55.70B | 47.54B | 42.18B | 13.85B |
| Gross Profit | 14.38B | 26.83B | 14.45B | 20.07B | 9.24B | 5.99B |
| EBITDA | 19.46B | 18.25B | 12.98B | 11.16B | 10.45B | 7.13B |
| Net Income | 10.26B | 9.25B | 5.39B | 2.28B | 1.44B | -70.06M |
Balance Sheet | ||||||
| Total Assets | 128.58B | 126.01B | 110.51B | 106.64B | 105.90B | 100.96B |
| Cash, Cash Equivalents and Short-Term Investments | 10.07B | 9.04B | 3.44B | 3.44B | 5.85B | 3.74B |
| Total Debt | 9.02B | 11.11B | 14.02B | 25.32B | 28.96B | 47.33B |
| Total Liabilities | 26.30B | 29.42B | 27.15B | 42.21B | 43.84B | 60.70B |
| Stockholders Equity | 102.28B | 96.59B | 83.36B | 64.43B | 62.07B | 40.27B |
Cash Flow | ||||||
| Free Cash Flow | 10.21B | 9.66B | 10.90B | 7.91B | 7.13B | -584.19M |
| Operating Cash Flow | 12.49B | 11.58B | 12.14B | 9.73B | 8.57B | -478.38M |
| Investing Cash Flow | -5.12B | -7.24B | -9.64B | -4.69B | -1.29B | -77.14B |
| Financing Cash Flow | -5.17B | -4.43B | -2.56B | -7.51B | -5.45B | 81.17B |
Sagility India Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SAGILITY, the sentiment is Negative. The current price of 42.00 is below the 20-day moving average (MA) of 44.04, below the 50-day MA of 44.44, and below the 200-day MA of 43.20, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 40.03 is Neutral, neither overbought nor oversold. The STOCH value of 34.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SAGILITY.
Sagility India Limited Peers Comparison
Overall Rating
IN:INDGN74Outperform- IN:SAGILITY68Neutral
IN:IKS64Neutral
IN:MEDPLUS56Neutral
IN:MEDIASSIST54Neutral
IN:TAKE45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:INDGN | 74Outperform | INR 141.61B | 34.30 | ― | 0.38% | 35.84% | -8.11% |
| IN:SAGILITY | 68Neutral | INR 196.62B | 19.13 | ― | 0.71% | 28.49% | 28.48% |
| IN:IKS | 64Neutral | INR 286.10B | 37.33 | ― | ― | ― | ― |
| IN:MEDPLUS | 56Neutral | INR 69.66B | 32.97 | ― | ― | 20.57% | 7.88% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:MEDIASSIST | 54Neutral | INR 22.17B | 23.19 | ― | 0.67% | 20.27% | 24.08% |
| IN:TAKE | 45Neutral | INR 1.59B | 12.29 | ― | ― | ― | -68.34% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:SAGILITY | Sagility India Limited | 42.00 | -10.11 | -19.40% | |
| IN:INDGN | Indegene Limited | 587.65 | 53.75 | 10.07% | |
| IN:MEDIASSIST | Medi Assist Healthcare Services Limited | 296.75 | -271.32 | -47.76% | |
| IN:MEDPLUS | MedPlus Health Services Ltd. | 579.80 | -242.25 | -29.47% | |
| IN:TAKE | TAKE Solutions Limited | 10.75 | -12.06 | -52.87% | |
| IN:IKS | Inventurus Knowledge Solutions Limited | 1707.95 | 71.40 | 4.36% |
Sagility India Limited Corporate Events
Sagility Reappoints Hari Gopalakrishnan to Board, Underscoring Strategic Continuity
Sagility Limited has announced that shareholders at its fifth annual general meeting approved the re-appointment of Mr. Hari Gopalakrishnan as a non-executive, non-independent director, in line with the rotational retirement provisions of the Compani...
Sagility clears Q1 FY27 unaudited results with limited review
Sagility Limited announced that its Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The disclosure was made in line with Regulation 33 of SEBI’s Listing Obligation...
Sagility posts robust Q1 FY27 growth and expands healthcare operations footprint
Sagility Limited reported strong unaudited results for Q1 FY27, with revenue rising 27.6% year-on-year to INR 19,635 million and adjusted EBITDA growing 27.9%, maintaining a 24.0% margin. Adjusted PAT climbed 35.1% and earnings per share rose sharply...
Sagility to Host Q1 FY27 Earnings Webinar for Investors on July 21
Sagility Limited has announced that it will host an earnings webinar for analysts and investors to discuss its unaudited financial results for the quarter ended June 30, 2026. The session, scheduled for July 21, 2026 at 7:30 p.m. IST via Zoom, will f...
Sagility Sets AGM Date and Record Date for FY 2025-26 Final Dividend
Sagility Limited has scheduled its Annual General Meeting for August 20, 2026, to be held via video conferencing, with the detailed notice and annual report for FY 2025-26 to be circulated separately. The company has set August 7, 2026, as the record...
Sagility Sets August 20 Virtual AGM and Final Dividend Record Date
Sagility Limited has scheduled its fifth Annual General Meeting for August 20, 2026, at 4:00 p.m. IST, to be conducted through video conferencing and other audio-visual means, with the detailed notice and annual report for FY 2025-26 to be circulated...
Sagility Clarifies Performance-Linked Structure of 2026 ESOP and PSU Plan
Sagility Limited has issued additional clarifications on its proposed Employee Stock Options and Performance Stock Units Scheme 2026, detailing a performance framework that ties at least 70% of incentives, especially for senior management, to core fi...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026